Owner TANABE SEIYAKU CO., LTD.

Inventors TAMURA, Takashi; TAKIGAWA, Masaharu; SAKURAI, Naoki; TAKAGI, Toshiki; YANAKA, Noriyuki; HORIKIRI, Yuji

Pub. Number AU-A-2002308877

PCT Number PCT/JP02/04930

PCT Pub. Number WO2002/094320

Priority 2001-154048 23.05.01 JP

Filing date 22 May 2002

Wipo publication date 3 December 2002

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 031/27

A61K 031/277

A61K 031/343 - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 031/381 - having five-membered rings

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/4166

A61K 031/42 - Oxazoles

A61K 031/423 - condensed with carbocyclic rings

A61K 031/44 - Non-condensed pyridines

A61K 031/4409 - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 031/4418 - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 031/4425 - Pyridinium derivatives, e.g. pralidoxime, pyridostigmine

A61K 031/4453 - only substituted in position 1, e.g. propipocaine, diperodon

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 031/4985 - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 031/50 - Pyridazines

A61K 031/501 - not condensed and containing further heterocyclic rings

A61K 031/502 - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61K 031/5025 - ortho- or peri-condensed with heterocyclic ring systems

A61K 031/519 - ortho- or peri-condensed with heterocyclic rings

A61K 031/522

A61K 031/5377

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 047/14 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 047/36 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 047/38 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 019/02 Drugs for skeletal disorders

A61K 009/10 Medicinal preparations characterised by special physical form - Dispersions

A61K 009/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 009/19 Medicinal preparations characterised by special physical form - lyophilised